Victory Capital Management Inc Legend Biotech Corp Transaction History

Victory Capital Management Inc

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 06, 2023	BUY	$63.16 - $76.5 $4,105 - $4,972	65 Added 0.36%	17,959 $1.21 Million
Q2 2023 Jul 27, 2023	BUY	$46.28 - $75.01 $828,134 - $1.34 Million	17,894 New	17,894 $1.24 Million
Q2 2022 Aug 01, 2022	SELL	$33.54 - $55.0 $283,882 - $465,520	-8,464 Closed	0 $0
Q1 2022 May 04, 2022	BUY	$31.02 - $48.18 $11,725 - $18,212	378 Added 4.67%	8,464 $340,000
Q4 2021 Feb 07, 2022	BUY	$41.14 - $56.98 $332,658 - $460,740	8,086 New	8,086 $377,000

198

74.2M

374K

387K

Ticker LEGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 167,403,008
Market Cap $8.5B
Description
Legend Biotech Corporation, a clinical-stage biopharmaceutical company, through its subsidiaries, engages in the discovery and development of novel cell therapies for oncology and other indications in the United States, China, and internationally. Its lead product candidate, LCAR- B38M, is a chimeric antigen receptor for the treatment of multipl...

Get notified when there are updates to the investment portfolio of Victory Capital Management Inc, based on Form 13F filings with the SEC.

Stay updated on Victory Capital Management Inc with notifications on news.